Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Researcher develops procedures for defining preclinical stages of Alzheimer's disease

Researcher develops procedures for defining preclinical stages of Alzheimer's disease

Low levels of hydrogen peroxide can slow down cell aging

Low levels of hydrogen peroxide can slow down cell aging

Nanoparticles could be used to deliver drugs to the brain to treat neurodegenerative diseases

Nanoparticles could be used to deliver drugs to the brain to treat neurodegenerative diseases

Genetically edited form of herpes simplex virus outperforms key vaccine candidate

Genetically edited form of herpes simplex virus outperforms key vaccine candidate

LipiDiDiet project shows positive effects of nutrient intervention in early Alzheimer’s disease

LipiDiDiet project shows positive effects of nutrient intervention in early Alzheimer’s disease

Researchers use AI tool to study the dynamics behind cancer, Alzheimer’s disease

Researchers use AI tool to study the dynamics behind cancer, Alzheimer’s disease

Research projects receive BTCA awards to develop new drugs

Research projects receive BTCA awards to develop new drugs

Researchers receive $2.6 million grant to examine tau-glycan interactions involved in Alzheimer's disease

Researchers receive $2.6 million grant to examine tau-glycan interactions involved in Alzheimer's disease

Metabolite of dietary soy may decrease key risk factor for dementia

Metabolite of dietary soy may decrease key risk factor for dementia

Researchers uncover a new cellular mechanism for disposing of misfolded proteins

Researchers uncover a new cellular mechanism for disposing of misfolded proteins

Enzyme SSH1 impairs disposal of damaged tau and mitochondria leaking toxins

Enzyme SSH1 impairs disposal of damaged tau and mitochondria leaking toxins

Researchers discover how synapses find energy to support intense neural conversations

Researchers discover how synapses find energy to support intense neural conversations

Vacuolar Tauopathy: New, rare genetic form of dementia discovered

Vacuolar Tauopathy: New, rare genetic form of dementia discovered

Epigenetic alterations drive late-onset Alzheimer's disease

Epigenetic alterations drive late-onset Alzheimer's disease

Study sheds light on how membrane proteins could be influenced by lipids

Study sheds light on how membrane proteins could be influenced by lipids

Biomarker for diagnosis of neurodegenerative diseases identified in the eye

Biomarker for diagnosis of neurodegenerative diseases identified in the eye

Alzheimer's disease may be driven by overactivation of fructose made in the brain

Alzheimer's disease may be driven by overactivation of fructose made in the brain

Star-shaped brain cells are essential for blood-brain barrier health, shows study

Star-shaped brain cells are essential for blood-brain barrier health, shows study

Smart drug delivery system may help treat spinal cord injuries and other neurological disorders

Smart drug delivery system may help treat spinal cord injuries and other neurological disorders

Protein aggregation reduces elasticity of blood vessels during aging

Protein aggregation reduces elasticity of blood vessels during aging

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.